Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. 2invest AG
  6. News
  7. Summary
    2INV   DE000A3H3L44

2INVEST AG

(2INV)
  Report
Real-time Estimate Tradegate  -  08:30 2022-11-28 am EST
9.050 EUR   -0.11%
09/06Theta Gold Mines Limited (asx : TGM) Issue of New Call Options to 2Invest AG
AQ
08/112invest AG Reports Earnings Results for the Half Year Ended June 30, 2022
CI
05/13Theta Gold Mines Limited (asx : TGM) Option to Extend Secure Bond Maturity Date
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Days
:
Hours
:
Minutes
:
Seconds

Heqet Therapeutics S.R.L. announced that it has received ú6.6 million in funding from Claris Ventures SGR SpA, 2invest AG

03/23/2022 EST

Heqet Therapeutics announced it has received £6.6 million in its series A round of funding led by new investors Claris Ventures SGR SpA and 2Invest AG on March 23, 2022. As part of the transaction Pietro Puglisi of Claris Ventures SGR SpA, Heikki Lanckriet of 2Invest, will join the board of the company as directors. The company issued common stock in the transaction.


ę S&P Capital IQ 2022
All news about 2INVEST AG
09/06Theta Gold Mines Limited (asx : TGM) Issue of New Call Options to 2Invest AG
AQ
08/112invest AG Reports Earnings Results for the Half Year Ended June 30, 2022
CI
05/13Theta Gold Mines Limited (asx : TGM) Option to Extend Secure Bond Maturity Date
AQ
04/202invest AG Reports Earnings Results for the Full Year Ended December 31, 2021
CI
03/23Heqet Therapeutics S.R.L. announced that it has received ú6.6 million in funding from C..
CI
03/16Kither Biotech s.r.l. announced that it has received €18.5 million in funding from..
CI
02/252invest : Preliminary annual results as of 31 December 2021
PU
20212invest : Change of forecast for the financial year 2021
PU
2021Revocation of the admission to the Prime Standard
PU
2021Leucid Bio Ltd announced that it has received ?11.5 million in funding from Epidarex Ca..
CI
More news
Financials
Sales 2021 1,99 M 2,07 M 2,07 M
Net income 2021 -1,89 M -1,96 M -1,96 M
Net cash 2021 42,8 M 44,6 M 44,6 M
P/E ratio 2021 -39,9x
Yield 2021 -
Capitalization 52,1 M 54,2 M 54,2 M
EV / Sales 2020 0,41x
EV / Sales 2021 16,3x
Nbr of Employees 4
Free-Float 31,0%
Chart 2INVEST AG
Duration : Period :
2invest AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends 2INVEST AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Hansj÷rg Plaggemars Chief Executive Officer
Alexander Link Chairman-Supervisory Board
Sebastian Paul VP-Finance & Administration
Rainer Herschlein Member-Supervisory Board
Eva Katheder Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
2INVEST AG-30.84%54
INVESTOR AB (PUBL)-14.54%58 371
CK HUTCHISON HOLDINGS LIMITED-13.42%21 356
GROUPE BRUXELLES LAMBERT SA-19.38%11 731
HAL TRUST-12.28%11 534
AB INDUSTRIVÄRDEN (PUBL)-5.69%11 259